Record numbers of men and women globally are now estimated to have reduced kidney function, a new study shows. Figures rose from 378 million people with the disease in 1990 to 788 million in 2023 as the world population grew ...
56 minutes ago
0
0
The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly reduce the risk of kidney disease progression, hospitalization, and death in people with and without ...
1 hour ago
0
0
Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and kidney- protective effects.
1 hour ago
0
0
An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney disease (CKD) would have benefits that outweigh the harm from a systolic blood pressure target of ...
1 hour ago
0
0
A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and death, a new study shows.
4 hours ago
0
5
The urinary albumin-creatinine ratio (UACR) is more strongly associated with kidney failure than the urinary protein-creatinine ratio (UPCR), according to research published online Nov. 4 in the Annals of Internal Medicine.
Nov 6, 2025
0
0
When the kidneys are damaged—after surgery, cardiac arrest, or as a side effect of certain medications—doctors often face one crucial question: Will the kidneys recover, or is the damage permanent?
Nov 6, 2025
0
0
The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins excreted in the urine of these patients. This reduction indicates that the degree ...
Nov 6, 2025
0
0
A study from the University of Cincinnati College of Medicine calls for more extensive nephrology fellowship training on reproductive health and the development of national guidelines on contraceptive counseling when treating ...
Nov 3, 2025
0
0
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by the World Health Organization (WHO) to inform ...
Oct 29, 2025
0
0
